微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 54.2% | -18.69% | 2.26% | 36/55 | 65.82% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 53.01% | -20.92% | -1.48% | 39/55 | 67.7% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 53.8% | -20.63% | -16.79% | 39/55 | 69.02% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 64.65% | 22.55% | -3.02% | 33/55 | 68.55% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 66.67% | 33.23% | -0.54% | 33/55 | 69.18% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 67.03% | 34.34% | -1.12% | 31/55 | 68.3% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 67.79% | 43.07% | 28.49% | 33/55 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 52.76% | -3.48% | 5.43% | 37/55 | 68.02% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 50.04% | -9.12% | 0.29% | 37/55 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 49.89% | -8.69% | 5.3% | 36/55 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 47.38% | -13.2% | -13.31% | 37/55 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 54.66% | -4.08% | -0.74% | 38/55 | 68.17% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 55.06% | -3.15% | 0.77% | 37/55 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 54.64% | -2.89% | 0.1% | 37/55 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 54.59% | -3.4% | -4.21% | 33/55 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 56.98% | -1.88% | 0.23% | 38/55 | 72.1% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 56.85% | -3.2% | 1.04% | 36/55 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 56.27% | -3.19% | -0.43% | 38/55 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 56.51% | -6.06% | -2.7% | 29/55 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 58.07% | -10.14% | -1.12% | 34/55 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
| 2020-09-30 | 58.73% | -3.19% | 1.05% | 28/55 | 73.64% | 义翘神州 | 96.56% | 行业排名> |
| 2020-06-30 | 58.12% | -4.74% | -3.38% | 35/55 | 88.2% | 华兰疫苗 | 707.43% | 行业排名> |
| 2020-03-31 | 60.15% | 0.23% | -6.92% | 24/55 | 70.26% | 我武生物 | 95.6% | 行业排名> |
| 2019-12-31 | 64.63% | 1.23% | 6.53% | 32/55 | 72.44% | 我武生物 | 96.43% | 行业排名> |
| 2019-09-30 | 60.67% | -1.31% | -0.57% | 21/55 | 70.09% | 我武生物 | 96.51% | 行业排名> |
| 2019-06-30 | 61.02% | 1.17% | 1.67% | 19/55 | 69.35% | 我武生物 | 96.46% | 行业排名> |
| 2019-03-31 | 60.01% | 2.54% | -5.99% | 18/55 | 69.07% | 我武生物 | 96.44% | 行业排名> |
| 2018-12-31 | 63.84% | -8.42% | 3.85% | 29/55 | 71.54% | 康辰药业 | 95.1% | 行业排名> |
| 2018-09-30 | 61.47% | -9.78% | 1.92% | 16/55 | 67.51% | 康辰药业 | 94.98% | 行业排名> |
| 2018-06-30 | 60.31% | -10.91% | 3.05% | 17/55 | 67.2% | 康辰药业 | 94.9% | 行业排名> |
| 2018-03-31 | 58.53% | -4.6% | -16.05% | 15/55 | 65.03% | 我武生物 | 93.37% | 行业排名> |
| 2017-12-31 | 69.71% | 10.59% | 2.32% | 23/55 | -887.82% | 我武生物 | 96.35% | 行业排名> |
| 2017-09-30 | 68.14% | 11.65% | 0.64% | 12/55 | 65.93% | 我武生物 | 97% | 行业排名> |
| 2017-06-30 | 67.7% | 10.65% | 10.35% | 13/55 | 63.83% | 我武生物 | 96.96% | 行业排名> |
| 2017-03-31 | 61.35% | 6.24% | -2.68% | 15/55 | 65.37% | 我武生物 | 97.16% | 行业排名> |
| 2016-12-31 | 63.04% | -1.67% | 3.3% | 19/55 | 68.41% | 欧林生物 | 99.46% | 行业排名> |
| 2016-09-30 | 61.02% | -4.51% | -0.26% | 14/55 | 63.02% | 我武生物 | 95.96% | 行业排名> |
| 2016-06-30 | 61.18% | -3.07% | 5.95% | 16/55 | -3007.12% | 欧林生物 | 99.4% | 行业排名> |
| 2016-03-31 | 57.74% | -9.1% | -9.93% | 14/55 | 61.6% | 我武生物 | 95.8% | 行业排名> |
| 2015-12-31 | 64.11% | 3.87% | 0.32% | 14/55 | 65.23% | 欧林生物 | 99.33% | 行业排名> |
| 2015-09-30 | 63.91% | 3.49% | 1.25% | 8/55 | 60.32% | 我武生物 | 95.02% | 行业排名> |
| 2015-06-30 | 63.12% | 5.13% | -0.64% | 10/55 | 61.38% | 我武生物 | 94.71% | 行业排名> |
| 2015-03-31 | 63.53% | 9.79% | 2.93% | 9/55 | 57.69% | 我武生物 | 95.59% | 行业排名> |